These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 235493)

  • 1. Partial purification and characterization of RTG-2 fish cell interferon.
    de Sena J; Rio GJ
    Infect Immun; 1975 Apr; 11(4):815-22. PubMed ID: 235493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production, purification and characterization of rat interferon.
    Lin LS; Abreu SL
    Arch Virol; 1979; 62(3):221-7. PubMed ID: 42377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid.
    Stewart WE; De Clercq E; Billiau A; Desmyter J; De Somer P
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1851-4. PubMed ID: 4505664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lymphoblastoid interferon. Large scale production and partial purification.
    Bridgen PJ; Anfinsen CB; Corley L; Bose S; Zoon KC; Rüegg UT; Buckler CE
    J Biol Chem; 1977 Oct; 252(19):6585-7. PubMed ID: 893430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification of human interferon by affinity chromatography.
    Anfinsen CB; Bose S; Corley L; Gurari-Rotman D
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3139-42. PubMed ID: 4370251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon: purification and initial characterization from human diploid cells.
    Knight E
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):520-523. PubMed ID: 1061154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and some properties of two boticins.
    Ellison JS; Kautter JA
    J Bacteriol; 1970 Oct; 104(1):19-26. PubMed ID: 4919745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of mouse interferon by sequential chromatography.
    Braude IA; De Clercq E
    J Chromatogr; 1979 Apr; 172():207-19. PubMed ID: 95020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial purification and characterization of Syrian hamster interferon.
    Bollin E; Sulkowski E
    J Gen Virol; 1981 Feb; 52(Pt 2):227-33. PubMed ID: 6169782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of purified mouse interferons.
    Knight E
    J Biol Chem; 1975 Jun; 250(11):4139-44. PubMed ID: 236313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and physico-chemical characterization of rabbit tumor necrosis factor.
    Ruff MR; Gifford GE
    J Immunol; 1980 Oct; 125(4):1671-7. PubMed ID: 6997383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of the inferferon-like virus inhibitor released during interaction of mouse sensitized lymphocytes with their target cells.
    Borecký L; Fuchsberger N; Zemla J; Lackovic V
    Eur J Immunol; 1971 Jun; 1(3):213-8. PubMed ID: 4331347
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification and partial characterization of human lymphoblast interferon.
    Zoon KC; Smith ME; Bridgen PJ; zur Nedden D; Anfinsen CB
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5601-5. PubMed ID: 293665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial purification and characterization of human gamma (immune) interferon.
    Yip YK; Pang RH; Urban C; Vilcek J
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1601-5. PubMed ID: 6165014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards large-scale purification of natural CSF-1 from human placenta tissue extracts.
    Martin-Thouvenin V; Uhlrich S; Tayot JL; Lanotte M
    Biotechnol Appl Biochem; 1990 Apr; 12(2):176-87. PubMed ID: 2184839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of interferon from mouse Ehrlich ascites tumor cells.
    Kawakita M; Cabrer B; Taira H; Rebello M; Slattery E; Weideli H; Lengyel P
    J Biol Chem; 1978 Jan; 253(2):598-602. PubMed ID: 563400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Pseudomonas aeruginosa slime production by staphylococcal extracellular product.
    Shibl AM; Al-Sowaygh IA
    J Clin Microbiol; 1980 Feb; 11(2):123-6. PubMed ID: 6766950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further purification and characterization of heat-stable enterotoxin produced by Yersinia enterocolitica.
    Okamoto K; Inoue T; Shimizu K; Hara S; Miyama A
    Infect Immun; 1982 Mar; 35(3):958-64. PubMed ID: 7068226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of QAE-Sephadex for the purification of two staphylococcal enterotoxins. I. Purification of enterotoxin C2.
    Robern H; Stavric S; Dickie N
    Biochim Biophys Acta; 1975 May; 393(1):148-58. PubMed ID: 237564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and biochemical characterization of an inhibitor of DNA synthesis produced by an Epstein-Barr virus-transformed B cell line.
    Beneke JS; Qualtiere LF; Nesheim MC; Pearson GR
    J Immunol; 1980 Jun; 124(6):2950-5. PubMed ID: 6246172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.